{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:41:37Z","timestamp":1790700097042,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the 23rd Batch of Student Scientific Research Project Approval of Jiangsu University","award":["Y23A164"],"award-info":[{"award-number":["Y23A164"]}]},{"name":"the Health Commission of the Sichuan Province Medical Science and Technology Program","award":["24WXXT10"],"award-info":[{"award-number":["24WXXT10"]}]},{"name":"the Sichuan Province Science and Technology Support Program","award":["2021YJ0242"],"award-info":[{"award-number":["2021YJ0242"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Chronic low-grade inflammation in nonalcoholic fatty liver disease (NAFLD) plays a critical role in the development of cardiovascular complications, particularly ischaemia with non-obstructive coronary arteries (INOCA). This study aimed to develop and evaluate models combining pericoronary adipose tissue (PCAT) radiomics, PCAT attenuation (PCATa), CCTA plaque parameters, and clinical risk factors to identify INOCA in NAFLD patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study included 159 patients with NAFLD who underwent CCTA. The patients were randomly divided into the training (70%) and validation (30%) cohorts. Clinical features, CCTA imaging indicators, and right coronary artery PCAT radiomic features were analyzed. Five models were constructed using logistic regression: Model 1 (PCATa model), Model 2 (radiomics model), Model 3 (clinical factors model), Model 4 (combined imaging model), and Model 5 (combined imaging-clinical model). The models\u2019 diagnostic performance was assessed using the area under the curve, reclassification metrics, and decision curve analysis (DCA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The PCAT radiomics model exhibited higher diagnostic efficacy than the PCATa model in identifying INOCA (training cohort: AUC 0.734 vs. 0.674; validation cohort: AUC 0.706 vs. 0.637). The combined imaging model showed improved performance over the clinical factors model (training AUC 0.830, validation AUC 0.813). The model integrating imaging and clinical factors achieved the highest diagnostic accuracy (AUCs of 0.873 and 0.824 in the training and validation cohorts, respectively), demonstrating incremental value based on improved NRI, IDI, and DCA metrics. Calibration analysis indicated good agreement between predicted and observed outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The radiomics model provided better discrimination than the PCATa model for identifying INOCA among patients with NAFLD. Models incorporating radiomics and CCTA imaging parameters outperformed those based solely on clinical factors. The comprehensive imaging-clinical model achieved the best overall performance and may serve as a promising non-invasive approach for INOCA risk stratification in NAFLD, although external validation is still required.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-025-05292-5","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T15:15:49Z","timestamp":1762960549000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Radiomics analysis of pericoronary adipose tissue for detecting ischaemia with non-obstructive coronary arteries in NAFLD patients"],"prefix":"10.1186","volume":"25","author":[{"given":"Lingli","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongming","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanbo","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaixiang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangju","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"issue":"10290","key":"5292_CR1","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397(10290):2212\u201324.","journal-title":"Lancet"},{"issue":"6","key":"5292_CR2","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1161\/ATV.0000000000000153","volume":"42","author":"PB Duell","year":"2022","unstructured":"Duell PB, Welty FK, Miller M, et al. Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American Heart Association. Arterioscler Thromb Vasc Biol. 2022;42(6):e168\u201385.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"5292_CR3","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1136\/gutjnl-2022-328105","volume":"72","author":"TG Simon","year":"2023","unstructured":"Simon TG, Roelstraete B, Alkhouri N, et al. Cardiovascular disease risk in paediatric and young adult non-alcoholic fatty liver disease. Gut. 2023;72(3):573\u201380.","journal-title":"Gut"},{"issue":"5","key":"5292_CR4","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/jgh3.12746","volume":"6","author":"A Gholoobi","year":"2022","unstructured":"Gholoobi A, Gifani M, Gholoobi A, et al. Relationship between the prevalence and severity of non-alcoholic fatty liver disease and coronary artery disease: findings from a cross-sectional study of a referral center in Northeast Iran. JGH Open. 2022;6(5):330\u20137.","journal-title":"JGH Open"},{"issue":"1","key":"5292_CR5","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.027466","volume":"12","author":"M Hjort","year":"2023","unstructured":"Hjort M, Eggers KM, Lakic TG, et al. Biomarker concentrations and their temporal changes in patients with myocardial infarction and nonobstructive compared with obstructive coronary arteries: results from the PLATO trial. J Am Heart Assoc. 2023;12(1):e27466.","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"5292_CR6","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1161\/CIRCULATIONAHA.116.024534","volume":"135","author":"MC Bairey","year":"2017","unstructured":"Bairey MC, Pepine CJ, Walsh MN, et al. Ischemia and no obstructive coronary artery disease (INOCA): developing Evidence-Based therapies and research agenda for the next Decade. Circulation. 2017;135(11):1075\u201392.","journal-title":"Circulation"},{"issue":"10444","key":"5292_CR7","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1016\/S0140-6736(24)00596-8","volume":"403","author":"K Chan","year":"2024","unstructured":"Chan K, Wahome E, Tsiachristas A, et al. Inflammatory risk and cardiovascular events in patients without obstructive coronary artery disease: the ORFAN multicentre, longitudinal cohort study. Lancet. 2024;403(10444):2606\u201318.","journal-title":"Lancet"},{"issue":"Suppl E","key":"5292_CR8","doi-asserted-by":"publisher","first-page":"E121","DOI":"10.1093\/eurheartj\/suaa076","volume":"22","author":"F Prati","year":"2020","unstructured":"Prati F, Marco V, Paoletti G, et al. Coronary inflammation: why searching, how to identify and treat it. Eur Heart J Suppl. 2020;22(Suppl E):E121\u20134.","journal-title":"Eur Heart J Suppl"},{"issue":"2","key":"5292_CR9","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jhep.2016.04.005","volume":"65","author":"SM Francque","year":"2016","unstructured":"Francque SM, van der Graaff D, Kwanten WJ. Non-alcoholic fatty liver disease and cardiovascular risk: pathophysiological mechanisms and implications. J Hepatol. 2016;65(2):425\u201343.","journal-title":"J Hepatol"},{"issue":"398","key":"5292_CR10","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aal2658","volume":"9","author":"AS Antonopoulos","year":"2017","unstructured":"Antonopoulos AS, Sanna F, Sabharwal N, et al. Detecting human coronary inflammation by imaging perivascular fat. Sci Transl Med. 2017;9(398):eaal2658.","journal-title":"Sci Transl Med"},{"issue":"42","key":"5292_CR11","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000039936","volume":"103","author":"C Zhang","year":"2024","unstructured":"Zhang C. Coronary heart disease evaluation using PCAT radiomics model based on coronary CT angiography and pericoronary adipose tissue. Medicine. 2024;103(42):e39936.","journal-title":"Medicine"},{"issue":"34","key":"5292_CR12","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000027043","volume":"100","author":"K Ichikawa","year":"2021","unstructured":"Ichikawa K, Miyoshi T, Osawa K, et al. Association between higher pericoronary adipose tissue attenuation measured by coronary computed tomography angiography and nonalcoholic fatty liver disease: a matched case-control study. Medicine. 2021;100(34):e27043.","journal-title":"Medicine"},{"issue":"3","key":"5292_CR13","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","volume":"41","author":"J Knuuti","year":"2020","unstructured":"Knuuti J, Wijns W, Saraste A, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407\u201377.","journal-title":"Eur Heart J"},{"issue":"1","key":"5292_CR14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1172\/JCI88883","volume":"127","author":"C Crewe","year":"2017","unstructured":"Crewe C, An YA, Scherer PE. The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis. J Clin Invest. 2017;127(1):74\u201382.","journal-title":"J Clin Invest"},{"issue":"2","key":"5292_CR15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41569-018-0097-6","volume":"16","author":"EK Oikonomou","year":"2019","unstructured":"Oikonomou EK, Antoniades C. The role of adipose tissue in cardiovascular health and disease. Nat Rev Cardiol. 2019;16(2):83\u201399.","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"5292_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-01748-0","volume":"22","author":"X Dong","year":"2023","unstructured":"Dong X, Li N, Zhu C, et al. Diagnosis of coronary artery disease in patients with type 2 diabetes mellitus based on computed tomography and pericoronary adipose tissue radiomics: a retrospective cross-sectional study[J]. Cardiovasc Diabetol. 2023;22(1):14.","journal-title":"Cardiovasc Diabetol"},{"issue":"43","key":"5292_CR17","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1093\/eurheartj\/ehz592","volume":"40","author":"EK Oikonomou","year":"2019","unstructured":"Oikonomou EK, Williams MC, Kotanidis CP, et al. A novel machine learning-derived radiotranscriptomic signature of perivascular fat improves cardiac risk prediction using coronary CT angiography. Eur Heart J. 2019;40(43):3529\u201343.","journal-title":"Eur Heart J"},{"issue":"6","key":"5292_CR18","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1007\/s00330-022-09306-0","volume":"33","author":"Z Ren","year":"2023","unstructured":"Ren Z, Wen D, Xue R, et al. Nonalcoholic fatty liver disease is associated with myocardial ischemia by CT myocardial perfusion imaging, independent of clinical and coronary CT angiography characteristics. Eur Radiol. 2023;33(6):3857\u201366.","journal-title":"Eur Radiol"},{"issue":"44","key":"5292_CR19","doi-asserted-by":"publisher","first-page":"4592","DOI":"10.1093\/eurheartj\/ehab282","volume":"42","author":"H Shimokawa","year":"2021","unstructured":"Shimokawa H, Suda A, Takahashi J, et al. Clinical characteristics and prognosis of patients with microvascular angina: an international and prospective cohort study by the coronary vasomotor disorders international study (COVADIS) group. Eur Heart J. 2021;42(44):4592\u2013600.","journal-title":"Eur Heart J"},{"key":"5292_CR20","doi-asserted-by":"publisher","first-page":"e60602","DOI":"10.1136\/bmj-2021-060602","volume":"375","author":"JF Beltrame","year":"2021","unstructured":"Beltrame JF, Tavella R, Jones D, et al. Management of ischaemia with non-obstructive coronary arteries (INOCA)[J]. BMJ. 2021;375:e60602.","journal-title":"BMJ"},{"issue":"9","key":"5292_CR21","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1007\/s10554-023-02879-x","volume":"39","author":"H Yang","year":"2023","unstructured":"Yang H, Teng H, Luo P, et al. The role of left ventricular hypertrophy measured by echocardiography in screening patients with ischaemia with non-obstructive coronary arteries: a cross-sectional study. Int J Cardiovasc Imaging. 2023;39(9):1657\u201366.","journal-title":"Int J Cardiovasc Imaging"},{"issue":"1","key":"5292_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2024.06.020","volume":"35","author":"N Li","year":"2025","unstructured":"Li N, Dong X, Zhu C, et al. Association study of NAFLD with pericoronary adipose tissue and pericardial adipose tissue: diagnosis of stable CAD patients with NAFLD based on radiomic features. Nutr Metab Cardiovasc Dis. 2025;35(1):103678.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"10","key":"5292_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11102838","volume":"11","author":"T Nishihara","year":"2022","unstructured":"Nishihara T, Miyoshi T, Ichikawa K, et al. Association of oxidized low-density lipoprotein in nonalcoholic fatty liver disease with high-risk plaque on coronary computed tomography angiography: a matched case-control study. J Clin Med. 2022;11(10):2838.","journal-title":"J Clin Med"},{"issue":"10151","key":"5292_CR24","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0140-6736(18)31114-0","volume":"392","author":"EK Oikonomou","year":"2018","unstructured":"Oikonomou EK, Marwan M, Desai MY, et al. Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data. Lancet. 2018;392(10151):929\u201339.","journal-title":"Lancet"},{"issue":"10","key":"5292_CR25","doi-asserted-by":"publisher","first-page":"7251","DOI":"10.1007\/s00330-021-07882-1","volume":"31","author":"R Ma","year":"2021","unstructured":"Ma R, van Assen M, Ties D, et al. Focal pericoronary adipose tissue attenuation is related to plaque presence, plaque type, and stenosis severity in coronary CTA. Eur Radiol. 2021;31(10):7251\u201361.","journal-title":"Eur Radiol"},{"issue":"6","key":"5292_CR26","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.jacc.2020.05.078","volume":"76","author":"EK Oikonomou","year":"2020","unstructured":"Oikonomou EK, Desai MY, Marwan M, et al. Perivascular fat attenuation index stratifies cardiac risk associated with high-risk plaques in the CRISP-CT study. J Am Coll Cardiol. 2020;76(6):755\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"5292_CR27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.atherosclerosis.2022.11.009","volume":"363","author":"PK Mehta","year":"2022","unstructured":"Mehta PK, Huang J, Levit RD, et al. Ischemia and no obstructive coronary arteries (INOCA): a narrative review. Atherosclerosis. 2022;363:8\u201321.","journal-title":"Atherosclerosis"},{"issue":"20","key":"5292_CR28","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1136\/heartjnl-2017-312324","volume":"104","author":"J Mancio","year":"2018","unstructured":"Mancio J, Oikonomou EK, Antoniades C. Perivascular adipose tissue and coronary atherosclerosis. Heart. 2018;104(20):1654\u201362.","journal-title":"Heart"},{"issue":"12","key":"5292_CR29","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1007\/s00380-022-02107-x","volume":"37","author":"K Ichikawa","year":"2022","unstructured":"Ichikawa K, Miyoshi T, Nakashima M, et al. Prognostic value of pericoronary adipose tissue attenuation in patients with non-alcoholic fatty liver disease with suspected coronary artery disease. Heart Vessels. 2022;37(12):1977\u201384.","journal-title":"Heart Vessels"},{"issue":"8","key":"5292_CR30","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jcmg.2021.02.026","volume":"14","author":"PA van Diemen","year":"2021","unstructured":"van Diemen PA, Bom MJ, Driessen RS, et al. Prognostic value of RCA pericoronary adipose tissue CT-attenuation beyond high-risk plaques, plaque volume, and ischemia. JACC Cardiovasc Imaging. 2021;14(8):1598\u2013610.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"5292_CR31","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.21037\/qims-21-1022","volume":"12","author":"J Shang","year":"2022","unstructured":"Shang J, Guo Y, Ma Y, et al. Cardiac computed tomography radiomics: a narrative review of current status and future directions. Quant Imaging Med Surg. 2022;12(6):3436\u201353.","journal-title":"Quant Imaging Med Surg"},{"issue":"1","key":"5292_CR32","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/RTI.0000000000000268","volume":"33","author":"M Kolossvary","year":"2018","unstructured":"Kolossvary M, Kellermayer M, Merkely B, et al. Cardiac computed tomography radiomics: a comprehensive review on radiomic techniques. J Thorac Imaging. 2018;33(1):26\u201334.","journal-title":"J Thorac Imaging"},{"issue":"1","key":"5292_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13244-024-01731-7","volume":"15","author":"Y Li","year":"2024","unstructured":"Li Y, Huo H, Liu H, et al. Coronary CTA-based radiomic signature of pericoronary adipose tissue predict rapid plaque progression. Insights Imaging. 2024;15(1):151.","journal-title":"Insights Imaging"},{"issue":"1156","key":"5292_CR34","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1093\/bjr\/tqae032","volume":"97","author":"M Jing","year":"2024","unstructured":"Jing M, Xi H, Sun J, et al. Differentiation of acute coronary syndrome with radiomics of pericoronary adipose tissue. Br J Radiol. 2024;97(1156):850\u20138.","journal-title":"Br J Radiol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05292-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-025-05292-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-025-05292-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T15:15:50Z","timestamp":1762960550000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-025-05292-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5292"],"URL":"https:\/\/doi.org\/10.1186\/s12872-025-05292-5","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"28 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was performed in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of the Affiliated Hospital of North Sichuan Medical College(No. 2024ER39-1). Given the retrospective design of the study, the requirement for informed consent was waived by the ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"803"}}